Expect 35% returns in Wyeth: Ranganathan

Published on Wed, Mar 26, 2008 at 15:38 |  Source : CNBC-TV18

Updated at Thu, Mar 27, 2008 at 11:23  

1757 Investors following Wyeth. Share this News with them.
0
0
Share on Tumblr
S Ranganathan, ., LKP Shares and Sec

Excerpts from Midcap Radar on CNBC-TV18 Watch the full show ยป

ALSO READ

S Ranganathan of LKP Shares and Sec is of the view that Wyeth should give returns of 35% for investors.

Ranganathan told CNBC-TV18, "Wyeth is in the domestic branded space and it has got very strong brands operating in areas with are fast growing like vaccines and the other brands, which are in the gastrointestinal segment because these are acute therapies where in a country like India, we see a lot of volume growth happening. The company already has a 6% dividend yield at these prices. They are sitting on high levels of cash and cash equivalent. It is India centric companies with a minimum or zero exposure to the US and other developed countries. They have not really gone through any fundamental change in their business, means their cost structure also."

He further added, "Typically, the promoters hold more than 50% and because of the fact that they are trading at the lower end of their price to earnings multiple over the last 3-4 years. So basically, you have companies like Wyeth where they are expected to grow their forward earnings at rates, which are higher than the Sensex growth on a valuation basis and compelling valuations in the sense that they trade substantially lower than Sensex valuations. Over a period of one-year, we do expect and believe that the stock should give returns upwards of 35% for investors."

  

Trending News

Business News

2TB drives offer best value for money
Did Sebi miss any tricks in Ambani consent order? "Did Sebi miss any tricks in Ambani consent order?"

Oppn gears up to make Bharat bandh a success

On Facebook IPO Morgan Stanley Speculation Of 'Nefarious Activity' Around IPO Untrue

The latest earning numbers FIRST on CNBC-TV18
Videos

May 30 2012, 23:16

Clash of Spain and ECB worrying investors: Verstrate

- in FII View

May 30 2012, 11:18

Result corner: Ajay Bodke`s top bets from across sectors

- in MARKET OUTLOOK

Interviews

May 30 2012, 17:04 | Source: CNBC-TV18

Margins may be hit on one-off items in EBITDA: Sun Pharma  

May 30 2012, 16:32 | Source: CNBC-TV18

Essar announces Rs 175cr deal; to pay-off debts with fund  

Subscribe to

Moneycontrol Newsletters

Moneycontrol.com offers you a choice of various sectoral and other newsletters for FREE!